Icon (MEX:ICLRN) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ICLRN Icon PLC MEX:ICLRN
96 GF Score
Price MXN1,850.28
GF Value MXN2,322.87
! 5 Warning Signs
View Full Analysis

What is Icon Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

MEX:ICLRN
96GF Score
Icon PLC MEX:ICLRN
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Icon (MEX:ICLRN) Overvalued in 2026?

Based on GuruFocus' analysis, Icon stock appears to be undervalued. The current stock price of MXN1,850.28 is trading 20.3% below its estimated GF Value™ of MXN2,322.87.

Key valuation signals for MEX:ICLRN:

  • Total Noninterest Expense:
  • GF Value™: MXN2,322.87 vs. price of MXN1,850.28 (20.3% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the MEX:ICLRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icon Business Description

Address South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
96GF Score

Get the complete analysis for MEX:ICLRN

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,850.28
Price
MXN2,322.87
GF Value